| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-02-24 | Thorp Clay Director | Purchase | +15,000 | +9.31%176,141 | $0.92 | $13,800 | View SEC filing | |
| 2024-11-04 | Chong Ngai Hang Victor Chief Medical Officer | Purchase | +36,500 | +57.48%100,000 | $1.00 | $36,500 | View SEC filing | |
| 2024-06-24 | Chong Ngai Hang Victor Chief Medical Officer | Purchase | +23,500 | +58.75%63,500 | $1.06 | $24,910 | View SEC filing | |
| 2024-05-15 | YERXA BENJAMIN R Director | Purchase | +7,813 | +77.02%17,957 | $1.31 | $10,235 | View SEC filing | |
| 2024-04-19 | Gibney Anthony S Director | Purchase | +100,000 | +100.00%100,000 | $1.30 | $129,665 | View SEC filing | |
| 2024-03-20 | Chong Ngai Hang Victor CHIEF MEDICAL OFFICER | Purchase | +30,000 | +100.00%30,000 | $1.60 | $48,000 | View SEC filing | |
| 2024-02-09 | WHITMORE BRADFORD T 10% Owner | Purchase | +888,888 | +21.94%4,939,478 | $0.68 | $599,999 | View SEC filing | |
| 2024-01-19 | LASEZKAY GEORGE M CEO | Sale | -18,000 | -3.71%466,577 | $1.27 | $22,860 | View SEC filing | |
| 2024-01-19 | Deignan Charles A. Chief Financial Officer | Sale | -12,900 | -3.24%384,662 | $1.28 | $16,512 | View SEC filing | |
| 2023-11-01 | WHITMORE BRADFORD T 10% Owner | Purchase | +135,778 | +3.47%4,050,590 | $0.74 | $99,849 | View SEC filing | |
| 2023-10-04 | Hutson Nancy J Director | Purchase | +10,000 | +12.05%93,000 | $0.86 | $8,600 | View SEC filing | |
| 2023-09-25 | Thorp Clay Director | Purchase | +10,000 | +32.76%40,522 | $0.86 | $8,600 | View SEC filing | |
| 2023-01-20 | Ciulla Thomas Chief Medical Officer | Sale | -13,700 | -4.48%291,890 | $1.47 | $20,139 | View SEC filing | |
| 2023-01-20 | LASEZKAY GEORGE M CEO | Sale | -20,030 | -3.97%484,577 | $1.46 | $29,244 | View SEC filing | |
| 2023-01-20 | Deignan Charles A. Chief Financial Officer | Sale | -14,030 | -3.72%363,472 | $1.50 | $21,045 | View SEC filing | |
| 2023-01-11 | Ciulla Thomas Chief Medical Officer | Sale | -2,170 | -0.71%305,590 | $1.62 | $3,515 | View SEC filing | |
| 2022-12-21 | Thorp Clay Director | Purchase | +14,000 | +84.74%30,522 | $1.02 | $14,266 | View SEC filing | |
| 2022-12-19 | Thorp Clay Director | Sale | -32,873 | -0.66%4,951,547 | $4.43 | $145,627 | View SEC filing | |
| 2022-11-21 | Hutson Nancy J Director | Purchase | +30,000 | +56.60%83,000 | $1.33 | $39,900 | View SEC filing | |
| 2022-01-20 | Deignan Charles A. Chief Financial Officer | Sale | -8,833 | -2.45%351,366 | $2.09 | $18,461 | View SEC filing | |
| 2022-01-20 | Ciulla Thomas Chief Medical Officer | Sale | -9,050 | -2.97%295,260 | $2.13 | $19,277 | View SEC filing | |
| 2022-01-20 | LASEZKAY GEORGE M CEO | Sale | -10,800 | -2.10%504,607 | $2.12 | $22,896 | View SEC filing | |
| 2022-01-13 | LASEZKAY GEORGE M CEO | Sale | -5,100 | -1.21%417,907 | $2.46 | $12,546 | View SEC filing | |
| 2021-09-23 | Ciulla Thomas Chief Medical Officer | Sale | -2,560 | -0.99%255,560 | $6.40 | $16,384 | View SEC filing | |
| 2021-09-23 | LASEZKAY GEORGE M CEO | Sale | -3,525 | -0.83%423,007 | $6.46 | $22,772 | View SEC filing |
1-25 of 90
